BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 24873781)

  • 1. Anti-Angiotensin type 1 receptor antibodies in chronic graft-versus-host disease.
    Chiron A; Bouaziz JD; Carmagnat M; Peffault de Latour R; Lafaurie-Bergeron A; Robin M; Xhaard A; Toubert A; Charron D; Guigue N; Socié G; Bengoufa D
    Transplantation; 2014 Aug; 98(4):470-4. PubMed ID: 24873781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host disease.
    Yaguchi S; Ogawa Y; Shimmura S; Kawakita T; Hatou S; Satofuka S; Nakamura S; Imada T; Miyashita H; Yoshida S; Yaguchi T; Ozawa Y; Mori T; Okamoto S; Kawakami Y; Ishida S; Tsubota K
    PLoS One; 2013; 8(6):e64724. PubMed ID: 23762250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation.
    Wechalekar A; Cranfield T; Sinclair D; Ganzckowski M
    Clin Lab Haematol; 2005 Aug; 27(4):247-9. PubMed ID: 16048492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genital chronic graft-versus-host disease in females: a cross-sectional study.
    Smith Knutsson E; Björk Y; Broman AK; Helström L; Levin Jakobsen AM; Nilsson O; Sundfeldt K; Brune M
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):806-11. PubMed ID: 24594123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Ro52 Autoantibodies Are Related to Chronic Graft-vs.-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation.
    Yang K; Chen Y; Qi H; Ye Y; Fan Z; Huang F; Zhang H; Suo Y; Liu Q; Jin H
    Front Immunol; 2020; 11():1505. PubMed ID: 32849514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue Renin-Angiotensin System in Lacrimal Gland Fibrosis in a Murine Model of Chronic Graft-Versus-Host Disease.
    Yaguchi S; Ogawa Y; Kawakita T; Shimmura S; Tsubota K
    Cornea; 2015 Nov; 34 Suppl 11():S142-52. PubMed ID: 26448172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimitochondrial antibodies in patients with chronic graft-versus-host disease.
    Siegert W; Stemerowicz R; Hopf U
    Bone Marrow Transplant; 1992 Sep; 10(3):221-7. PubMed ID: 1422476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of autoantibody expression in allogeneic stem-cell recipients.
    Moon JH; Lee SJ; Kim JG; Chae YS; Kim SN; Kang BW; Suh JS; Lee KS; Sohn SK
    Transplantation; 2009 Jul; 88(2):242-50. PubMed ID: 19623021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin ulcers related to chronic graft-versus-host disease: clinical findings and associated morbidity.
    Jachiet M; de Masson A; Peffault de Latour R; Rybojad M; Robin M; Bourhis JH; Xhaard A; Dhedin N; Sicre de Fontbrune F; Suarez F; Barete S; Parquet N; Nguyen S; Ades L; Rubio MT; Wittnebel S; Bagot M; Socié G; Bouaziz JD
    Br J Dermatol; 2014 Jul; 171(1):63-8. PubMed ID: 24404963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of the ratio of regulatory and effector T cells with recurrence and chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang HT; Zhao XY; Zhao XS; Han TT; Lv M; Chang YJ; Huang XJ
    Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):679-84. PubMed ID: 23978019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential value of autoantibodies as biomarkers of chronic graft-versus-host disease after allogeneic stem cell transplantation.
    Hao B; Gao S; Sang YW; Wang L; Meng XQ; You JY
    J Zhejiang Univ Sci B; 2019 Oct.; 20(10):849-860. PubMed ID: 31489804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-angiotensin II type 1 receptor autoantibodies (AT
    İlgen U; Yayla ME; Düzgün N
    Rheumatol Int; 2017 Apr; 37(4):593-598. PubMed ID: 28004166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis.
    Budding K; van de Graaf EA; Hoefnagel T; Kwakkel-van Erp JM; van Kessel DA; Dragun D; Hack CE; Otten HG
    J Cyst Fibros; 2015 Jan; 14(1):42-5. PubMed ID: 25096855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against human cytomegalovirus late protein UL94 in the pathogenesis of scleroderma-like skin lesions in chronic graft-versus-host disease.
    Pastano R; Dell'Agnola C; Bason C; Gigli F; Rabascio C; Puccetti A; Tinazzi E; Cetto G; Peccatori F; Martinelli G; Lunardi C
    Int Immunol; 2012 Sep; 24(9):583-91. PubMed ID: 22773152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased donor CD86+CD14+ cells in the bone marrow and peripheral blood of patients with chronic graft-versus-host disease.
    Arpinati M; Chirumbolo G; Marzocchi G; Baccarani M; Rondelli D
    Transplantation; 2008 Jun; 85(12):1826-32. PubMed ID: 18580477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies (ANCA) in chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Martin SJ; Audrain MA; Oksman F; Ecoiffier M; Attal M; Milpied N; Esnault VL
    Bone Marrow Transplant; 1997 Jul; 20(1):45-8. PubMed ID: 9232255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive dental caries in patients with oral chronic graft-versus-host disease.
    Castellarin P; Stevenson K; Biasotto M; Yuan A; Woo SB; Treister NS
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1573-9. PubMed ID: 22516054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
    Urbano-Ispizua A; García-Conde J; Brunet S; Hernández F; Sanz G; Petit J; Bargay J; Figuera A; Rovira M; Solano C; Ojeda E; de la Rubia J; Rozman C
    Haematologica; 1997; 82(6):683-9. PubMed ID: 9499667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.
    Ahmad I; Labbé AC; Chagnon M; Busque L; Cohen S; Kiss T; Lachance S; Roy DC; Sauvageau G; Roy J
    Biol Blood Marrow Transplant; 2011 Nov; 17(11):1673-8. PubMed ID: 21601640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.